Go to the list of all blogs
Jimmy Landsman's Avatar
published in Blogs
Sep 11, 2026
Tradr 2X Long IREN Daily ETF (IREX) Delivers +16% Rebound in 30 Days as IREN Advances AI Transition

Tradr 2X Long IREN Daily ETF (IREX) Delivers +16% Rebound in 30 Days as IREN Advances AI Transition

Key Takeaways

  • IREX rose about 16% over the last 30 days, climbing from roughly $13.19 to $15.33, as its sole underlying stock, IREN Limited, rebounded from July lows.
  • IREX is a leveraged single-stock ETF that seeks 200% of IREN's daily return rather than a diversified index or sector basket.
  • The rebound was driven by IREN's accelerating AI-cloud transition, including new multi-year contracts and a Microsoft data-center acceptance milestone.
  • Despite the monthly gain, IREX remains down roughly 65% over the last quarter, reflecting the amplified and compounding effect of daily 2x leverage during a drawdown.
  • Because leverage resets daily, IREX's multi-day performance can diverge significantly from twice IREN's return over the same period.

Understanding the Tradr 2X Long IREN Daily ETF (IREX) Structure

IREX seeks daily investment results, before fees and expenses, that correspond to 200% of the daily performance of the common shares of IREN Limited (NASDAQ: IREN). The fund does not track a broad index and does not pursue its objective over periods longer than a single trading day. It is a leveraged single-stock product that resets its exposure each session, a structure that creates compounding and "volatility drag" effects over multi-day holding periods.

The portfolio is deliberately concentrated. Rather than holding a basket of securities, IREX holds a small number of positions—effectively a total return swap providing 200% exposure to IREN plus cash and other net assets. The fund carries a net expense ratio of 1.30%, has assets under management (AUM) of roughly $55 million, and launched on October 22, 2025.

Because IREX is entirely levered to one company, its ETF performance is a direct, magnified function of IREN's stock. IREN operates renewable-energy-powered data centers in North America and is pivoting from Bitcoin mining toward AI-cloud and high-performance-computing hosting, a strategy that has made it a supplier to major cloud and GPU vendors. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Price Performance: Last 30 Days Compared to the Quarter

Over the last 30 days, IREX advanced about +16%, from a closing level near $13.19 to approximately $15.33. The move was anything but gradual: the fund traded in an exceptionally wide range, sinking below $8.31 in late July before surging above $20 intraday in mid-August and then consolidating back toward the mid-teens. This pattern reflects sharp, news-driven swings in IREN multiplied by daily 2x leverage.

The quarterly picture is starkly different. Three months earlier, IREX closed near $44.43, meaning the fund has fallen roughly -65% over the last quarter despite the recent rebound. The divergence between the monthly gain and the quarterly decline highlights how quickly this product can reverse and how daily rebalancing compounds losses during volatile stretches.

What Supported the 30-Day Advance

The recent advance was almost entirely a function of IREN's AI-cloud momentum. In late July, IREN signed roughly $2.8 billion of new multi-year cloud-services contracts and raised its end-of-2026 AI-cloud annualized run-rate revenue target above $4 billion, sending IREN sharply higher and lifting IREX by more than 60% in a single session.

The rally extended in mid-August after MSFT formally accepted Horizon 1, the first of four 50-megawatt AI data centers under IREN's five-year, $9.7 billion Microsoft agreement. NVDA separately granted the deployment "Exemplar Cloud" status for its GB300 NVL72 systems. These milestones provided tangible evidence that IREN's transition from Bitcoin mining to AI infrastructure is converting contract announcements into operating capacity.

A rebound in Bitcoin also supported sentiment, since IREN retains a substantial—though shrinking—mining business. The move was reinforced by a recovery from deeply oversold July levels, when the fund and its underlying stock had been hit by concerns over declining mining revenue and the financing burden of the AI buildout.

Drivers of the Quarterly Decline

The quarterly decline reflects a broader reversal in the Bitcoin-mining and AI-infrastructure complex. IREN rallied roughly 40% in May on an NVIDIA partnership and the acquisitions of Mirantis and Nostrum Group, lifting IREX toward its early-June peak. That momentum then reversed as investors weighed a mining revenue "air pocket": IREN's Bitcoin-mining revenue fell sharply year over year even as its newer AI-cloud business scaled rapidly but remained a minority of total revenue.

Sector-wide, former Bitcoin miners competing for the same hyperscaler and GPU demand—including APLD and WULF—experienced similar swings. Macroeconomic considerations, including interest-rate expectations and the capital intensity of AI data-center buildouts, added pressure. Because IREX applies 2x leverage daily, the underlying drawdown was compounded, producing a quarterly loss far larger than twice IREN's own decline.

Using Tickeron’s AI Screener in My Analysis

I often turn to Tickeron’s AI Screener when evaluating leveraged products like this one. The platform lets me apply technical indicators, volatility filters, and industry screens across thousands of securities in one place, which helps surface comparable setups or confirm momentum conditions without manual charting. It has become a regular part of how I review single-stock ETFs and their underlying names before forming a view on short-term trading opportunities.

Outlook and Risks to Monitor

The near-term focus is IREN's fiscal 2026 results and forward commentary, where execution—not headline contract value—will be the key test. Investors should monitor the commissioning of Horizons 2–4, progress toward the company's target of roughly 480 megawatts of AI-cloud capacity and 150,000 GPUs by the end of 2026, and whether contracted revenue converts into reported cash flow.

Bitcoin price action remains relevant, given IREN's residual mining operations and the historical correlation of the broader miner complex to crypto sentiment. Interest-rate expectations, AI-infrastructure capital spending, and the financing terms behind large GPU purchases will also shape the investment theme, as will dilution risk from the company's convertible notes and equity-based acquisitions.

Finally, IREX's structure is itself a material risk factor. Daily-reset 2x leverage magnifies both gains and losses and can erode value through volatility drag even when the underlying stock is roughly flat over a holding period. The fund is best understood as a short-term trading tool rather than a long-term portfolio building block.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: IREX

Contributor

My name is Jimmy, and I’m a financial analyst focused on identifying compelling opportunities across the ETF market. Each day, I analyze hundreds of ETFs to uncover potential trading and investment opportunities using a broad range of market factors. For short-term trading, I rely heavily on technical analysis, including price channels, momentum indicators, support and resistance levels, trend patterns, and other market signals. At the same time, I dedicate significant attention to evaluating ETFs from a long-term investment perspective. My objective is to build a well-balanced ETF portfolio that combines core investment holdings with more tactical and speculative positions. The goal is to create a portfolio that can participate effectively in market rallies while also remaining resilient during periods of volatility and market corrections.


Momentum Indicator for IREX turns positive, indicating new upward trend

IREX saw its Momentum Indicator move above the 0 level on September 04, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 14 similar instances where the indicator turned positive. In of the 14 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for IREX just turned positive on September 03, 2026. Looking at past instances where IREX's MACD turned positive, the stock continued to rise in of 7 cases over the following month. The odds of a continued upward trend are .

IREX moved above its 50-day moving average on September 04, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +2 3-day Advance, the price is estimated to grow further. Considering data from situations where IREX advanced for three days, in of 39 cases, the price rose further within the following month. The odds of a continued upward trend are .

IREX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 7 cases where IREX's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IREX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for IREX entered a downward trend on August 07, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Industry description

The investment seeks daily investment results, before fees and expenses, that correspond to two times (200%) the daily performance of the common shares of IREN Limited. Under normal market circumstances, the fund will maintain at least 80% exposure to financial instruments that provide two times leveraged exposure to the daily performance of IREN. This may include IREN stock in addition to financial instruments. The fund is non-diversified.
View a ticker or compare two or three
IREX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Category Trading

Profile
Details
Category
Trading--Leveraged Equity
Address
Investment Managers Series Trust II803 West Michigan StreetMilwaukee
Phone
(414) 299-2295
Web
N/A
Interact to see
Advertisement
HIMS shares surged approximately +43.85% in premarket trading on Monday, March 9, 2026, rising from a prior close of $15.74 to around $22.80. Primary catalyst: Novo Nordisk officially ended its patent infringement lawsuit against Hims & Hers and announced a landmark partnership to distribute branded Wegovy through the Hims platform at $599/month.
XENE shares surged approximately +45.93% in premarket trading on March 9, 2026, one of the largest single-session moves in the company's history. The primary catalyst: Xenon announced positive topline Phase 3 X-TOLE2 results for its lead drug candidate azetukalner in focal onset seizures (FOS), meeting the primary endpoint with overwhelming statistical significance.
Shares of OLMA dropped approximately 41% in Monday's session, one of the steepest single-day declines in the company's history. The primary catalyst was Roche's Phase 3 persevERA trial failure — a late-stage study of giredestrant, a closely competing selective estrogen receptor degrader (SERD), which missed its primary endpoint of statistically significant improvement in progression-free survival.
RLMD shares surged approximately +40% at the open on March 9, 2026, rising from a prior close of $4.45 to approximately $6.23, driven by a major clinical trial readout. The primary catalyst was the announcement of 12-month interim data from the Phase 2 trial of NDV-01, Relmada's lead oncology candidate, in patients with high-risk non-muscle invasive bladder cancer (NMIBC) — results that significantly exceeded historical benchmarks.
CRCL surged +8.66% on Monday, March 9, 2026, rising from a prior close of $101.94 to trade at $110.77 intraday. The primary catalyst is a landmark stablecoin milestone: Circle's USDC overtook Tether as the dominant stablecoin by transfer volume, accounting for approximately 70% of all stablecoin transfer activity as total stablecoin transfers hit $1.8 trillion in February.
Carnival Corporation (CCL) shares fell approximately -7.60% in Monday's session, dropping from a Friday close of $25.79 to around $23.83. The primary catalyst is a broad market sell-off driven by intensifying recession fears, with the S&P 500 and consumer discretionary names bearing the brunt of the pressure.
Shares of Bloom Energy (BE) are surging approximately +10.30% in Monday's session, rebounding sharply from a steep -15.50% selloff on Friday, March 6, 2026. Friday's decline was triggered by an Oracle-OpenAI data center project update that spooked energy infrastructure investors; Monday's move reflects aggressive dip-buying and a sentiment reset.
IGV has rallied about 8–9% in the last 6 trading days, while SOXX has dropped about 8%, giving software a +16.6 percentage‑point edge—the largest 6‑day software‑over‑semi outperformance ever.[barchart]​ This comes right after software lagged semis by almost −15 percentage points into late January, the widest gap since 2008, and as hedge‑fund short exposure to U.S. software and services hit a record ~3.8% of market cap.
Crude’s explosive war‑driven spike faded on March 9 because the market suddenly started to price less extreme, shorter‑lived supply risk and more policy intervention, not a multi‑month shortage. WTI, which had briefly traded above 115–120 dollars on Iran‑war headlines and Strait of Hormuz fears, slid back toward the high‑80s as traders digested G7 reserve‑release talk, Trump’s comments about a “brief” war, and the reality that prices had run far ahead of fundamentals.
Shares of ARQ plunged approximately 27.50% in premarket trading on March 10, 2026, from a prior close of $3.20 to roughly $2.32. The primary catalyst was a deeply disappointing Q4 2025 earnings report, which revealed a net loss of $50.0 million for the quarter versus a net loss of $1.3 million in Q4 2024.
RAIL shares fell approximately 15% in premarket trading on March 10, 2026, following a steep after-hours reaction to disappointing Q4 2025 earnings results released after the close on March 9. The primary catalyst was a significant revenue miss: Q4 revenue came in at $125.6 million, well below consensus estimates near $144–$160 million, representing an 8.8% year-over-year decline.
ZVRA shares surged approximately +17.86% on March 10, 2026, driven by a blockbuster Q4 and full-year 2025 earnings report released before the market open. Primary catalyst: Q4 2025 EPS of $0.19 crushed the consensus estimate of $0.05 — a 280% beat — while revenue of $34.1 million exceeded forecasts by 21.57%.
LITE surged +14.73% on Monday, March 9, 2026, closing at $640.69 versus a prior close of $558.44 on March 6. The primary catalyst was the landmark $2 billion strategic investment by NVIDIA announced March 2, with the market continuing to price in its full implications following a brief post-announcement pullback.
Shares of BNTX fell approximately 22% on Tuesday, March 10, 2026, following a dual shock of disappointing full-year guidance and a surprise leadership upheaval. The primary catalyst was BioNTech's Q4 2025 earnings report, which included a 2026 revenue outlook of €2.0–€2.3 billion — well below analyst consensus and signaling continued pressure from declining COVID-19 vaccine demand.
CNC shares fell approximately 10% during Tuesday's session, extending a prolonged selloff in the managed care sector. The primary catalyst is intensifying investor concern over federal Medicaid and ACA funding cuts tied to the "One Big Beautiful Bill Act" (OBBBA), which threatens to shrink the government-sponsored insurance pools that Centene depends on for the majority of its revenue.
Technology recently peaked near 35% of the S&P 500 and has slipped over the last year, while Energy plus Materials remain near historically low combined weight at roughly 6%, which suggests the gap is still unusually wide.
Average daily equity purchases by retail investors on S&P 500 down days in 2026 are at the highest level on record, running about 100% above the peak intensity seen during the 2021 meme‑stock boom.
Over the past two weeks, PLTR has climbed from roughly the high‑130s to the mid‑150s, a gain of about 12–14%, with a series of strong up days between March 2 and March 6.
AVAV shares dropped approximately 10% in premarket trading on March 11, 2026, following a disappointing Q3 fiscal 2026 earnings report released after the prior session's close. Q3 revenue of $408.0 million came in far below analyst consensus of approximately $475–$488 million, representing a massive top-line miss.
KOS shares are down approximately 20% in premarket trading on March 11, 2026, having shed roughly 20.31% across the last two sessions (Tuesday close and premarket Wednesday). The primary catalyst is Kosmos Energy's announcement of a massive $185.25 million public equity offering priced at $1.90 per share — a steep discount to recent trading levels.